Far Infrared Radiation Treatment of Dementia and Other Mental Illness

Sponsor

GAAD Medical Research Institute Inc. (Other)

Overall Status

Unknown status

CT.gov ID

NCT00574054

Collaborator

(none)

Enrollment

Location

Arm

12.9

Duration (Months)

0.3

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

This trial is a preliminary study to determine the use of far infrared radiation for the treatment of dementia and other mental sickness.

Condition or Disease	Intervention/Treatment	Phase
Dementia	Radiation: Far Infrared	Phase 1

Detailed Description

Dementia is the progressive decline in cognitive function due to damage or disease in the brain beyond what might be expected from normal aging. Particularly affected areas include memory, attention, language, and problem solving. Especially in the later stages of the condition, affected persons may be disoriented in place and in person (not knowing who they are).

The prevalence of dementia is rising as the global life expectancy is rising. Particularly in Western countries, there is increasing concern about the economic impact that dementia will have in future, older populaces.

It is a disease that is strongly associated with age; 1% of those aged 60-65, 6% of those aged 75-79, and 45% of those aged 95 or older suffer from the disease.

We are postulating that the use of far infrared radiation on the central nervous system, the endocrine system and the viscera will have a positive effect on treating dementia and other neurological illnesses.

Study Design

Study Type:

Interventional

Actual Enrollment :

4 participants

Allocation:

Non-Randomized

Intervention Model:

Single Group Assignment

Masking:

None (Open Label)

Primary Purpose:

Treatment

Official Title:

Phase 1 Study to Evaluate the Efficacy of Using Energy Specific Far Infrared Radiation Treatment for Dementia and Other Related Mental Illness.

Study Start Date :

Feb 1, 2008

Anticipated Primary Completion Date :

Jan 1, 2009

Anticipated Study Completion Date :

Mar 1, 2009

Arms and Interventions

Arm	Intervention/Treatment
Other: 1	Radiation: Far Infrared Far infrared radiation (5 μm to 20 μm wavelength) for 30 to 40 minutes per treatment session.

Arm

Intervention/Treatment

Other: 1

Radiation: Far Infrared

Far infrared radiation (5 μm to 20 μm wavelength) for 30 to 40 minutes per treatment session.

Outcome Measures

Primary Outcome Measures

The primary end point is to determine the therapeutic effects of far infrared radiation on dementia. [1 year]

Secondary Outcome Measures

The secondary end point of the study is to evaluate the therapeutic effects of far infrared radiation on other related mental illness including Alzheimer's, multiple sclerosis and stroke rehabilitation. [1 year]

Eligibility Criteria

Criteria

Ages Eligible for Study:

2 Years and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

Persons age 2 or older, with dementia, Alzheimer's, Huntington's disease, Parkinson's disease, Down's syndrome, multiple sclerosis or stroke

Exclusion Criteria:

Persons with severe mental illness that are confined to mental hospitals etc., as defined by the USA Diagnostic and Statistical Manual of Mental Disorders (DSM)

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	The Centre for Incurable Diseases	Toronto	Ontario	Canada	M4V 1L5

Sponsors and Collaborators

GAAD Medical Research Institute Inc.

Investigators

Principal Investigator: Kwasi Donyina, Ph.D., GAAD Medical Research Institute Inc.
Study Director: Ken Nedd, M.D., GAAD Medical Research Institute Inc.